Stay updated on Avutometinib Combo in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page
- Check6 days agoChange DetectedNo additions or deletions detected; the Study Details page appears unchanged between screenshots.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check34 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference3%

- Check41 days agoChange DetectedUpdated contact information is added and the page version is upgraded from v3.0.2 to v3.1.0. The most significant change is the page revision, with a large addition of external contact details.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page now includes an estimated timestamp for the last update, replacing the previous exact/alternative wording. Overall impact is a minor update to time-related content.SummaryDifference0.0%

- Check56 days agoChange DetectedUpdated to 35 locations (including Vancouver, WA) and added new contacts/investigators (Susan Papenfuse; Anthony Van Ho, MD; Kartik Konduri, MD); removed the old 34-location entry and former PI; revision bumped to v3.0.2.SummaryDifference2%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

Stay in the know with updates to Avutometinib Combo in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.